111 related articles for article (PubMed ID: 31301362)
1. Cleavage and polyadenylation specific factor 4 promotes colon cancer progression by transcriptionally activating hTERT.
Yang Q; Fan W; Zheng Z; Lin S; Liu C; Wang R; Li W; Zuo Y; Sun Y; Hu S; Chen M; Guo P; Pan J; Tian C; Zhu T; Diao C; Hao J; Yu W; Li L; Li Y; Guo W; Deng W; Wu X
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1533-1543. PubMed ID: 31301362
[TBL] [Abstract][Full Text] [Related]
2. CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas.
Chen W; Qin L; Wang S; Li M; Shi D; Tian Y; Wang J; Fu L; Li Z; Guo W; Yu W; Yuan Y; Kang T; Huang W; Deng W
Mol Oncol; 2014 May; 8(3):704-16. PubMed ID: 24618080
[TBL] [Abstract][Full Text] [Related]
3. Cleavage and polyadenylation specific factor 4 targets NF-κB/cyclooxygenase-2 signaling to promote lung cancer growth and progression.
Yi C; Wang Y; Zhang C; Xuan Y; Zhao S; Liu T; Li W; Liao Y; Feng X; Hao J; Gao Y; Yu W; Chen Y; Zhang C; Guo W; Tang B; Deng W
Cancer Lett; 2016 Oct; 381(1):1-13. PubMed ID: 27450326
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of cleavage and polyadenylation specific factor 4 in lung adenocarcinoma and its critical role for cancer cell survival and proliferation.
Chen W; Guo W; Li M; Shi D; Tian Y; Li Z; Wang J; Fu L; Xiao X; Liu QQ; Wang S; Huang W; Deng W
PLoS One; 2013; 8(12):e82728. PubMed ID: 24358221
[TBL] [Abstract][Full Text] [Related]
5. Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4.
Zhang N; Xie Y; Tai Y; Gao Y; Guo W; Yu W; Li J; Feng X; Hao J; Gao Y; Zhao X; Liao Y; Jiang W; Liu G; Deng W; Cui X
Cell Physiol Biochem; 2016; 40(6):1559-1569. PubMed ID: 27997899
[TBL] [Abstract][Full Text] [Related]
6. CREB-binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway.
Tang Z; Yu W; Zhang C; Zhao S; Yu Z; Xiao X; Tang R; Xuan Y; Yang W; Hao J; Xu T; Zhang Q; Huang W; Deng W; Guo W
Mol Oncol; 2016 Feb; 10(2):317-29. PubMed ID: 26628108
[TBL] [Abstract][Full Text] [Related]
7. MiR-4458 inhibits breast cancer cell growth, migration, and invasiveness by targeting CPSF4.
Wu J; Miao J; Ding Y; Zhang Y; Huang X; Zhou X; Tang R
Biochem Cell Biol; 2019 Dec; 97(6):722-730. PubMed ID: 30970220
[TBL] [Abstract][Full Text] [Related]
8. SPT6 recruits SND1 to co-activate human telomerase reverse transcriptase to promote colon cancer progression.
Diao C; Guo P; Yang W; Sun Y; Liao Y; Yan Y; Zhao A; Cai X; Hao J; Hu S; Yu W; Chen M; Wang R; Li W; Zuo Y; Pan J; Hua C; Lu X; Fan W; Zheng Z; Deng W; Luo G; Guo W
Mol Oncol; 2021 Apr; 15(4):1180-1202. PubMed ID: 33305480
[TBL] [Abstract][Full Text] [Related]
9. RIF1 promotes human epithelial ovarian cancer growth and progression via activating human telomerase reverse transcriptase expression.
Liu YB; Mei Y; Long J; Zhang Y; Hu DL; Zhou HH
J Exp Clin Cancer Res; 2018 Aug; 37(1):182. PubMed ID: 30075819
[TBL] [Abstract][Full Text] [Related]
10. CPSF4 promotes tumor-initiating phenotype by enhancing VEGF/NRP2/TAZ signaling in lung cancer.
Song Y; Sun K; Gong L; Shi L; Qin T; Wang S; Deng W; Chen W; Zheng F; Li G
Med Oncol; 2022 Dec; 40(1):62. PubMed ID: 36567417
[TBL] [Abstract][Full Text] [Related]
11. RBFOX3 Promotes Tumor Growth and Progression via hTERT Signaling and Predicts a Poor Prognosis in Hepatocellular Carcinoma.
Liu T; Li W; Lu W; Chen M; Luo M; Zhang C; Li Y; Qin G; Shi D; Xiao B; Qiu H; Yu W; Kang L; Kang T; Huang W; Yu X; Wu X; Deng W
Theranostics; 2017; 7(12):3138-3154. PubMed ID: 28839469
[TBL] [Abstract][Full Text] [Related]
12. CDC5L Promotes hTERT Expression and Colorectal Tumor Growth.
Li J; Zhang N; Zhang R; Sun L; Yu W; Guo W; Gao Y; Li M; Liu W; Liang P; Deng W; Cui X
Cell Physiol Biochem; 2017; 41(6):2475-2488. PubMed ID: 28472785
[TBL] [Abstract][Full Text] [Related]
13. NUDT21 inhibits bladder cancer progression through ANXA2 and LIMK2 by alternative polyadenylation.
Xiong M; Chen L; Zhou L; Ding Y; Kazobinka G; Chen Z; Hou T
Theranostics; 2019; 9(24):7156-7167. PubMed ID: 31695759
[No Abstract] [Full Text] [Related]
14. Suppressor of Ty homolog-5, a novel tumor-specific human telomerase reverse transcriptase promoter-binding protein and activator in colon cancer cells.
Chen R; Zhu J; Dong Y; He C; Hu X
Oncotarget; 2015 Oct; 6(32):32841-55. PubMed ID: 26418880
[TBL] [Abstract][Full Text] [Related]
15. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
[TBL] [Abstract][Full Text] [Related]
16. Cleavage and Polyadenylation-Specific Factor 4 (CPSF4) Expression Is Associated with Enhanced Prostate Cancer Cell Migration and Cell Cycle Dysregulation, In Vitro.
Choudhry M; Gamallat Y; Ghosh S; Bismar TA
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629142
[TBL] [Abstract][Full Text] [Related]
17. BPTF promotes hepatocellular carcinoma growth by modulating hTERT signaling and cancer stem cell traits.
Zhao X; Zheng F; Li Y; Hao J; Tang Z; Tian C; Yang Q; Zhu T; Diao C; Zhang C; Chen M; Hu S; Guo P; Zhang L; Liao Y; Yu W; Chen M; Zou L; Guo W; Deng W
Redox Biol; 2019 Jan; 20():427-441. PubMed ID: 30419422
[TBL] [Abstract][Full Text] [Related]
18. Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth.
Zhang N; Zhang R; Zou K; Yu W; Guo W; Gao Y; Li J; Li M; Tai Y; Huang W; Song C; Deng W; Cui X
Cell Death Dis; 2017 Jul; 8(7):e2961. PubMed ID: 28749462
[TBL] [Abstract][Full Text] [Related]
19. An hTERT/ZEB1 complex directly regulates E-cadherin to promote epithelial-to-mesenchymal transition (EMT) in colorectal cancer.
Qin Y; Tang B; Hu CJ; Xiao YF; Xie R; Yong X; Wu YY; Dong H; Yang SM
Oncotarget; 2016 Jan; 7(1):351-61. PubMed ID: 26540342
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase reverse transcriptase (hTERT) promotes gastric cancer invasion through cooperating with c-Myc to upregulate heparanase expression.
Tang B; Xie R; Qin Y; Xiao YF; Yong X; Zheng L; Dong H; Yang SM
Oncotarget; 2016 Mar; 7(10):11364-79. PubMed ID: 26689987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
